Chemours
CC | NYSE
$13.53
+$0.34 (+2.58%)
At close: Oct 30, 2026, 3:59 PM ET
$13.65
+$0.12 (+0.89%)
Pre-market:
Nov 2, 2026, 7:54 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.59 | 29.14 | -19.71 | 8.23 | 9.09 | 18.64 |
PEG Ratio | 0.01 | -0.21 | 0.14 | 10.12 | 0.05 | -0.04 |
PS Ratio | 0.31 | 0.44 | 0.77 | 0.70 | 0.87 | 0.82 |
PB Ratio | 7.09 | 4.18 | 6.37 | 4.30 | 5.12 | 5.02 |
P/FCF Ratio | 34.76 | -2.54 | 25.25 | 10.62 | 10.31 | 7.56 |
P/OCF Ratio | 6.71 | -3.99 | 8.45 | 6.30 | 6.80 | 5.06 |
OCF/S Ratio | 4.55 | -10.95 | 9.15 | 11.05 | 12.83 | 16.24 |
Debt / Equity Ratio | 18.34 | 7.21 | 5.83 | 3.50 | 3.69 | 5.26 |
Quick Ratio | 0.85 | 0.86 | 1 | 0.96 | 1.21 | 1.17 |
Current Ratio | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 | 1.83 |
Asset Turnover | 0.79 | 0.77 | 0.74 | 0.89 | 0.84 | 0.70 |
Interest Coverage | -0.02 | 1.68 | -0.59 | 4.82 | 3.64 | 2.13 |
Return on Equity | -154.40% | 14.24% | -32.29% | 52.21% | 56.24% | 26.94% |
Return on Assets | -5.23% | 1.14% | -2.88% | 7.57% | 8.05% | 3.09% |
Return on Invested Capital | -0.09% | 5.16% | -1.56% | 10.50% | 10.50% | 7.83% |
Dividend Yield | 4.40% | 5.86% | 3.17% | 3.24% | 2.96% | 4.02% |
Payout Ratio | -20.21% | 172.09% | -62.60% | 26.64% | 26.97% | 74.89% |
FCF Payout Ratio | 260% | -14.68% | 89.22% | 36.58% | 32.60% | 31.30% |
Gross Profit Margin | 15.53% | 19.91% | 21.49% | 23.66% | 21.77% | 21.47% |
Net Profit Margin | -6.65% | 1.49% | -3.92% | 8.46% | 9.58% | 4.41% |
Pretax Profit Margin | -4.77% | 2.20% | -5.23% | 10.85% | 10.65% | 3.60% |
Operating Profit Margin | -0.09% | 7.66% | -2.02% | 11.51% | 10.62% | 9.02% |
FCF Margin | 0.88% | -17.17% | 3.06% | 6.56% | 8.46% | 10.87% |
EBITDA Margin | 5.72% | 11.97% | 3.24% | 17.49% | 18.57% | 15.44% |
Add to Watchlist
Select watchlists to add or remove CC